This condition results from the presence of maternal antibodies against paternal platelet antigen (Human Placental Antigen, HPA-1a).
The Fetal Institute uses state-of-the-art ultrasound technology to evaluate all pregnancies. This includes 2-D, 3-D, and 4-D ultrasound, color, pulsed, and M-mode Doppler, with the latest technological features available. Special software, including artificial intelligence with pattern recognition and assessment of fetal cardiac function, is an integral part of the technology used in our examinations. Patients are assured that no higher level of ultrasound technology exists for their consultations.
Our group specializes in the assessment, counseling and management of patients with high-risk pregnancies in Florida.